ANTI-AGING CATALYST COMPOSITION CONTAINING A HIGH-CONTENT BLEND OF COSMETIC ACIDS

Abstract

ANTI-AGING CATALYST COMPOSITION CONTAINING A HIGH-CONTENT COSMETIC ACID MIXTURE An anti-aging catalyst composition includes a combination of cosmetically acceptable acids comprising at least three alpha-hydroxy acids, at least one beta-hydroxy acid, and one or more other cosmetically acceptable acids, the total amount of cosmetically acceptable acids in the anti-aging catalyst composition being in the range of approximately 5% to approximately 70%, each of the cosmetically acceptable acids in the anti-aging catalyst composition being in the range of approximately 0.1% to approximately 69%, wherein the anti-aging catalyst composition has a pH ranging from approximately pH 1 to approximately pH 5.5. Figure for the abstract: none

Description

Title of the invention: ANTI-AGING CATALYST COMPOSITION CONTAINING A HIGH-CONTENT COSMETIC ACID MIXTURE FIELD OF THE INVENTION

[0001] The present invention relates, in general, to an anti-aging catalyst composition used as a catalyst prior to the application of anti-aging skincare compositions. The anti-aging catalyst enhances the anti-aging benefits of any anti-aging skincare routine, as demonstrated by the improvement in skin properties, particularly on the face, for example, by reducing wrinkles and fine lines on the forehead and providing a greater radiance than with the use of the anti-aging composition or treatment regimen alone. BACKGROUND OF THE INVENTION

[0002] There are a variety of skin conditions that benefit from cosmetic products that can be applied to the skin to brighten the complexion, reduce one or more fine lines on the face, dullness, dryness, tightness, brown spots, and reduce the effects of acne or inflammatory lesions, improve desquamation and skin renewal, and activate the proliferation of new skin cells, among other possible benefits. Many skincare products offer active ingredients that treat one or more of these or other skin problems, but there are challenges in developing products that contain sufficiently high amounts of active ingredients to provide the desired benefits.

[0003] Therefore, there is a need in the technique for a composition that can increase the effectiveness of anti-aging skin care products, in particular a composition and treatment regimens that can modulate, improve, reduce or reverse the manifestation of dermatological signs of chronological aging, hormonal aging or photoaging of the skin.

[0004] The inventors have proposed an anti-aging catalyst composition that is pre-applied to the skin prior to an anti-aging skincare composition or regimen. Compared to the skincare composition or regimen alone, the anti-aging catalyst composition used prior to the application of an anti-aging skincare composition or regimen has demonstrated, statistically and clinically, according to the inventors, that it attenuates more visible fine lines and improves radiance immediately after the initial application, and that it confers a statistically more significant reduction in the number of wrinkles / fine lines. on the forehead at week 8. In some embodiments, the anti-aging catalyst composition may confer an improvement in tissue desquamation, epidermal development, cell cycle and cell division. BRIEF SUMMARY OF THE INVENTION

[0005] This summary is provided to present a selection of concepts in a simplified form, which are described in greater detail below in the detailed description of the invention. This summary is not intended to identify key features of the claimed subject matter or to be used as an aid in determining the scope of the claimed subject matter.

[0006] In various embodiments, the invention includes an anti-aging catalyst composition comprising: a mixture of cosmetically acceptable acids comprising at least one beta-hydroxy acid and at least three alpha-hydroxy acids, and one or more other cosmetically acceptable acids; and a cosmetically acceptable solvent comprising at least water, wherein the pH of the skincare composition is in a range of about pH 3.6 to about pH 3.9.

[0007] This disclosure describes examples of embodiments in accordance with the general inventive concepts and is not intended to limit the scope of the invention in any way. Indeed, the invention as described in the patent application is broader than, and not limited by, the examples of embodiments presented herein, and the terms used herein have their full ordinary meaning. DETAILED DESCRIPTION OF THE INVENTION

[0008] In some embodiments, the anti-aging catalyst composition is in the form of a serum that may exclude oils, surfactants, and emulsifiers. In some embodiments, the anti-aging catalyst composition is in the form of an emulsion and therefore comprises an oil phase that includes one or more oils and may include one or more surfactants or emulsifiers or combinations thereof. In some embodiments, the anti-aging catalyst composition is in the form of a gel.

[0009] In the context of the invention, a serum refers to a hydrophilic liquid composition formulated for topical application. A serum may optionally be free or substantially free of one or more of an oil, including an emollient, a wax, a surfactant, an emulsifier, a silicone oil, or a combination or all of the foregoing.

[0010] The expressions "Exclude", "Exempt" and "Essentially exempt" mean that, although it is preferable that no excluded material be present in the anti-aging catalyst composition, it is possible to have very small quantities of the excluded material in the anti-aging catalyst composition of the invention, provided that these quantities do not materially affect the advantageous properties of the composition of anti-aging catalyst. In particular, "essentially free" means that the excluded material may be present in the composition of anti-aging catalyst in an amount of less than 5%, or less than 4%, or less than 3%, or less than 2%, or less than 1%, or less than 0.1% by weight, or 0%, relative to the total weight of the composition of anti-aging catalyst.

[0011] In some embodiments, the anti-aging catalyst composition is free or substantially free of at least one active ingredient selected from the group consisting of ascorbic acid and other forms of vitamin C, ferulic acid, gallic acid, zinc PCA, azelaic acid, chlorogenic acid and vitamin E, or one of their combinations.

[0012] In certain embodiments, the anti-aging catalyst composition is free from or minimizes the use of non-renewable ingredients (for example, mineral oil and petroleum-based ingredients) and ingredients that have a negative environmental impact (for example, EDTA, which mobilizes heavy metals). Thus, in certain embodiments, the anti-aging catalyst composition is free from or essentially free from ingredients selected from the group consisting of parabens, phthalates, cyclomethicones, silicone, mineral oil, petroleum-based ingredients, synthetic dyes, sulfates, polyquaternium, microplastics, EDTA, silicone oils, mineral UV blockers, organic UV blockers, or combinations thereof.

[0013] As shown herein, the inventors have proposed an anti-aging catalyst composition, given herein by way of example, to confer unexpectedly one or more benefits, including, but not limited to: conferring, when applied to the skin prior to the application of a skincare composition or anti-aging skin treatment regimen, a statistically significant improvement in visible fine lines and radiance immediately after the initial application; reducing the number of wrinkles / fine lines on the forehead at week 8 compared with the use of the skincare composition or anti-aging skin treatment regimen alone, as shown in the study results included in this document.

[0014] When combined with anti-aging routines, the anti-aging catalyst composition is capable of enhancing the skin's anti-aging benefits, as illustrated by the reduction of forehead wrinkles and fine lines compared to the routines alone. The active ingredients in the anti-aging routines combined with the anti-aging catalyst include, but are not limited to: antioxidants (including vitamins C, E, and their derivatives), chemical exfoliants, retinols, niacinamide, panthenol, glycerin, squalane, ceramides, collagen, hyaluronic acid, peptides, plant and fruit extracts, and sunscreens.

[0015] When combined with anti-aging routines, for example, but not limited to, antioxidant (AOX) treatments, AHA scrubs, retinol products, the anti-aging catalyst can enhance radiance immediately after application.

[0016] When combined with antioxidant formulations, the anti-aging catalyst can improve AOX protection compared to the formulation alone.

[0017] The use of the anti-aging skincare composition can include one application per day, morning or night, after cleansing and before treatment with an anti-aging skincare composition or regimen. The anti-aging skincare composition can be used year-round. Application involves a soaked cotton pad (1 drop) or directly by hand (8 to 10 drops). After applying the anti-aging skincare composition, the skincare regimen can be applied at any time, immediately up to 6 hours later.

[0018] The anti-aging skin care composition can be associated with anti-aging devices for home use (for example, red light based devices).

[0019] Accordingly, in various embodiments, the anti-aging catalyst composition is proposed according to the detailed description that follows.

[0020] Cosmetically acceptable acids (acid-based skin actives)

[0021] The anti-aging catalyst composition includes a combination of cosmetically acceptable acids, the combination of cosmetically acceptable acids including a combination of at least three alpha-hydroxy acids, at least one beta-hydroxy acid, and one or more other cosmetically acceptable acids. In some embodiments, the anti-aging catalyst composition includes at least lactic acid, glycolic acid, mandelic acid, salicylic acid, and phytic acid. In some particular embodiments, the anti-aging catalyst composition includes only lactic acid, glycolic acid, mandelic acid, salicylic acid, and phytic acid.

[0022] The anti-aging catalyst composition is a water-based serum form that may be a rinse-off or leave-on formulation, wherein the anti-aging catalyst composition has a viscosity that is fluid when applied. In some embodiments, the anti-aging catalyst composition may be supplied infused in a suitable substrate or contained in a dispenser.

[0023] In various embodiments, the total cosmetically acceptable amount of acid is present in a range of approximately 1% to approximately 70%, or approximately 5% to approximately 70%, or approximately 5% to approximately 20%, or approximately 5% to approximately 10%, or approximately 5% to approximately 8%, by weight, relative to the total weight of the anti-aging catalyst composition, and, if necessary, a neutralizing agent may be present to provide a pH in a range of approximately pH 3.6 to approximately pH 9, or approximately pH 1 at approximately pH 5.5, and in some embodiments from approximately pH 3.5 to pH 3.9. In some particular embodiments, the anti-aging catalyst composition has a pH of 3.7.

[0024] In various embodiments, where appropriate, the neutralizing agent is present in a range of about 0.1% to about 5%, by weight, relative to the total weight of the anti-aging catalyst composition. Alpha-hydroxy acids

[0025] The anti-aging catalyst composition comprises at least three alpha-hydroxy acids. In certain particular embodiments, the at least three alpha-hydroxy acids include glycolic acid, lactic acid, and mandelic acid.

[0026] Suitable alpha-hydroxy acids include glycolic acid, lactic acid, mandelic acid, tartaric acid, citric acid, their ester derivatives, or combinations thereof. Examples of ester derivatives include lactic acid ester compounds, such as methyl lactate, ethyl lactate, butyl lactate, and similarly, ester compounds of glycolic acid, tartaric acid, mandelic acid, and citric acid. A particularly suitable alpha-hydroxy acid is lactic acid. Lactic acid, or 2-hydroxypropanoic acid, is provided in the composition to provide enhanced skin exfoliation. In addition, lactic acid also stimulates the production of glycosaminoglycans (GAGs) in the skin, thereby improving the skin's barrier function and hydration.

[0027] The anti-aging catalyst composition may include a total alpha-hydroxy acid concentration of approximately 0.3% to approximately 69%, or approximately 0.3% to approximately 20%, or approximately 1% to approximately 15%, or approximately 2.5% to approximately 6%, or approximately 5.5%, or any suitable combination, subcombination, range, or subrange of these values ​​by weight relative to the weight of the anti-aging catalyst composition. However, those skilled in the art will appreciate that other ranges fall within the scope of the invention. In some embodiments, the total amount of alpha-hydroxy acid present is not more than approximately 10%, or not more than approximately 6%. In various embodiments, each of the cosmetically acceptable acids in the anti-aging catalyst composition is present in a range of about 0.1% to about 69%, in which the anti-aging catalyst composition has a pH ranging from about pH 1 to about pH 5.5.

[0028] In certain particular embodiments, alpha-hydroxy acid is present in a range of approximately 0.1% to approximately 5% and, in some embodiments, is present at approximately 2.5%, lactic acid is present in a range of approximately 0.1% to approximately 5% and, in some embodiments, is present at approximately 2%, and mandelic acid is present in a range of approximately 0.1% to approximately 5% and, in In some embodiments, it is present at approximately 1% by weight of the anti-aging catalyst composition.

[0029] In some embodiments, the total amount of cosmetically acceptable alpha-hydroxy acids is present in a range of about 0.3% to about 15% and, in some embodiments, is about 5.5% by weight of the anti-aging catalyst composition.

[0030] Thus, any one or combination of alpha-hydroxy acids, as appropriate, may be present, by weight, relative to the total weight of the anti-aging catalyst composition, at a rate of about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, to about 15 or up to about 69%, by weight, relative to the weight of the anti-aging catalyst composition, including intermediate increments and ranges. Beta-hydroxy acids

[0031] The anti-aging catalyst composition comprises at least one beta-hydroxy acid. In certain specific embodiments, the anti-aging catalyst composition may include a beta-hydroxy acid comprising salicylic acid. In certain specific embodiments, the anti-aging catalyst composition includes only a beta-hydroxy acid comprising salicylic acid.

[0032] The term "beta-hydroxy acid" refers, according to the present invention, to a carboxylic acid having a hydroxyl functional group and a carboxylic functional group separated by two carbon atoms. A beta-hydroxy acid may be present in the anti-aging catalyst composition in the form of the free acid and / or in the form of one of its associated salts (salts with an organic base or an alkali metal, in particular), depending notably on the final pH imposed on the anti-aging catalyst composition.

[0033] Suitable beta-hydroxy acids include salicylic acid and its derivatives (including 5-n-octanoylsalicylic acid, salicylate, sodium salicylate, and a willow extract), capryloylsalicylic acid, beta-hydroxybutanoic acid, propionic acid, beta-hydroxy beta-methylbutyric acid, tropic carnitine acid and trethocanic acid, and their combinations.

[0034] And in certain particular embodiments, the beta-hydroxy acid in the anti-aging catalyst composition may include at least one of salicylic acid and its derivatives (including 5-n-octanoylsalicylic acid, salicylate, sodium salicylate, and willow extract), capryloylsalicylic acid, beta-hydroxybutanoic acid, propionic acid, beta-hydroxy beta-methylbutyric acid, tropical carnitine acid, and trethocanic acid.

[0035] The anti-aging catalyst composition includes a beta-hydroxy acid concentration in the range of approximately 0.1% to and not more than approximately 2% beta-hydroxy acid, in weight, relative to the total weight of the anti-aging catalyst composition. In some embodiments, the anti-aging catalyst composition may include up to and not more than about 2%, or about 1.9%, of beta-hydroxy acid. In some embodiments, the anti-aging catalyst composition may include up to and not more than about 1% of beta-hydroxy acid. In some embodiments, the amount of beta-hydroxy acid, if any, is not more than about 0.40% to about 0.50%.

[0036] In certain embodiments, the anti-aging catalyst composition may include from about 0.1% to about 1% of beta-hydroxy acid, or from about 0.2% to about 2.0%, or from about 0.1% to about 1.5%, or from about 0.2% to about 1.5%, or from about 0.3% to about 1.0%, or from about 0.35% to about 0.75%, or from about 0.4% to about 0.5%, or is about 0.45%, or any appropriate combination, subcombination, range, or subrange of these values ​​by weight, relative to the weight of the anti-aging catalyst composition. However, those skilled in the art will appreciate that other ranges fall within the scope of the invention.

[0037] Thus, at least one beta-hydroxy acid is present in the anti-aging catalyst composition at a rate of approximately 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, to approximately 2.0 or up to approximately 69%, by weight, relative to the weight of the anti-aging catalyst composition, including increments and all intermediate ranges and sub-ranges. Other acids#; phytic acid

[0038] The anti-aging catalyst composition includes one or more other cosmetically acceptable acids that are not alpha- or beta-hydroxy acids.

[0039] In some embodiments, the anti-aging catalyst composition may include phytic acid. Phytic acid is also known as phytate and is a sextuple dihydrogen phosphate ester of inositol (specifically, of the myo isomer), also called inositol hexakisphosphate (IP6) or inositol polyphosphate. At physiological pH, the phosphates are partially ionized, yielding the phytate anion. Phytic acid occurs naturally in plant seeds and constitutes a storage form of phosphorus.

[0040] Phytic acid may be present in the anti-aging catalyst composition in an amount of approximately 0.5% to approximately 69%, or approximately 0.5% to approximately 15%, or approximately 0.5% to approximately 5%, and in some embodiments, approximately 1% to approximately 4%, and in some embodiments, approximately 1.5% to approximately 2.5%, or approximately 2%, or any appropriate combination, subcombination, range, or subrange of these values ​​by weight relative to the weight of the anti-aging catalyst composition. As given by way of example in this disclosure, the phytic acid raw material may be supplied at a 50% dilution or otherwise as disclosed herein.

[0041] Thus, in various embodiments, phytic acid, if applicable, may be present in the anti-aging catalyst composition according to the disclosure, and each of the individual components in the ranges as described above, from about 0.50, 0.60, 0.70, 0.80, 0.90, 1.0, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, to about 15 percent or up to about 69 percent by weight, relative to the weight of the anti-aging catalyst composition, including intermediate increments and ranges. Amino acid

[0042] The anti-aging catalyst composition may include at least one amino acid. In some embodiments, the at least one amino acid may be selected from the group consisting of naturally occurring amino acids. In some embodiments, the at least one amino acid comprises taurine.

[0043] By way of non-limiting examples, the amino acids that may be used may be of natural or synthetic origin, in L, D, or racemic form, and comprise at least one acidic function selected, for example, from among carboxylic acid, sulfonic acid, phosphonic acid, and phosphoric acid functions. The amino acids may be in their neutral or ionic form. Polymeric forms are also useful, such as polyarginine, polylysine, etc. Further non-limiting examples include basic amino acids comprising an additional amine function optionally included in a ring or in a ureido function.In some cases, amino acids that may be used include, but are not limited to, taurine, aspartic acid, glutamic acid, alanine, arginine, omithine, citrulline, asparagine, camitine, cysteine, glutamine, glycine, histidine, lysine, isoleucine, leucine, methionine, N-phenylalanine, proline, serine, threonine, tryptophan, tyrosine, ornithine, citrulline, and valine.

[0044] According to the various embodiments, the amount of amino acid, for example taurine, present in a composition according to the disclosure may range from about 0.1% to about 10%, or from about 0.2% to about 9%, or from about 0.5% to about 8%, or from about 0.8% to about 2%, or about 1%, or any appropriate combination, subcombination, range, or subrange of these values ​​by weight relative to the weight of the composition. In some embodiments according to the disclosure, the composition includes at least about 0.5%, or at least about 1% of at least one amino acid. In some embodiments according to the disclosure, the composition includes no more than about 1% of at least one amino acid. However, those skilled in the art will appreciate that other ranges fall within the scope of the invention.

[0045] Thus, any one or a combination of the amino acid, for example taurine, may be present, by weight, relative to the total weight of the composition, or from about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5 to about 10.0 percent, by weight, relative to the weight of the anti-aging catalyst composition, including increments and intermediate ranges. Solvents

[0046] The anti-aging catalyst composition includes water and optionally one or more water-soluble solvents.

[0047] According to the various embodiments, water is present in the anti-aging catalyst composition in a range of approximately 10% to approximately 99%, or approximately 30% to approximately 95%, or approximately 50% to approximately 90%, or approximately 75% to approximately 85%, or any suitable combination, sub-combination, range, or sub-range of these values ​​by weight, relative to the total weight of the anti-aging catalyst composition. However, those skilled in the art will appreciate that other ranges fall within the scope of the invention.

[0048] Thus, water can be present by weight, relative to the weight of the anti-aging catalyst composition, at a rate of approximately 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98 at approximately 99 percent by weight, y including intermediate increments and ranges.

[0049] The water used may be sterile demineralized water and / or floral water such as rose water, cornflower water, chamomile water or linden water, and / or natural thermal or mineral water such as, for example: Vittel water, Vichy basin water, Uriage water, La Roche-Posay water, La Bourboule water, Enghien-les-Bains water, Saint-Gervais-les-Bains water, Néris-les-Bains water, Allevar-les-Bains water, Digne water, Maizières water, Neyrac-les-Bains water, Lons-le-Saunier water, Eaux-Bonnes water, Rochefort water, Saint-Christau water, Les Fumades, Tercis-les-Bains water or Avène water. The aqueous phase may also include reconstituted thermal water, that is to say water containing trace elements such as zinc, copper, magnesium etc., reconstituting the characteristics of thermal water.

[0050] The pH of the anti-aging catalyst composition is adjusted according to the amount of acid cosmetically acceptable to be within a range as stated above. The pH is adjusted to the desired value by adding a base (organic or inorganic), for example sodium hydroxide, potassium hydroxide, or another suitable base, or a combination thereof. Water-soluble solvents

[0051] In some embodiments, the anti-aging catalyst composition may include at least one water-soluble solvent. The term "water-soluble solvent" is interchangeable with the term "water-miscible solvent" and refers to a compound that is liquid at 25°C and atmospheric pressure (760 mmHg), and that has a solubility of at least 50% in water under these conditions. In some cases, the water-soluble solvent has a solubility of at least 60%, 70%, 80%, or 90% in water under these conditions. Non-limiting examples of water-soluble solvents include, for example, glycerin, alcohols (for example, selected from water-soluble C1-C30, C1-C15, C1-C10 or C1-C4 alcohols), organic solvents, polyols, glycols, or mixtures thereof.

[0052] In certain particular embodiments as disclosed, if applicable, a water-soluble solvent may include glycerin.

[0053] By way of example of organic solvents, the following may be cited without limitation: ethyl alcohol, isopropyl alcohol, propyl alcohol, benzyl alcohol, and phenylethyl alcohol, or glycols or glycol ethers such as, for example, monomethyl, monoethyl, and monobutyl ethers of ethylene glycol, propylene glycol, or their ethers such as, for example, monomethyl ether of propylene glycol, butylene glycol, hexylene glycol, dipropylene glycol, as well as alkyl ethers of diethylene glycol, for example, monoethyl ether or monobutyl ether of diethylene glycol. Other suitable examples of organic solvents are ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, propanediol, and glycerin. Organic solvents may be volatile or non-volatile compounds.

[0054] Other non-limiting examples of water-soluble solvents include alkanols (polyhydric alcohols such as glycols and polyols) such as glycerin, 1,2,6-hexanetriol, trimethylolpropane, ethylene glycol, propylene glycol, diethylene glycol, butylene glycol, hexylene glycol, triethylene glycol, tetraethylene glycol, pentaethylene glycol, dipropylene glycol, 1,3-butanediol, 2,3-butanediol, 1,4-butanediol, 3-methyl-1,3-butanediol, 1,5-pentanediol, tetraethylene glycol, 1,6-hexanediol, 2-methyl-2,4-pentanediol, polyethylene glycol, 1,2,4-butanetriol, 1,2,6-hexanetriol, 2-butene-1,4-diol, 2-ethyl-1,3-hexanediol, 2-methyl-2,4-pentanediol, (caprylyl glycol), 1,2-hexanediol, 1,2-pentanediol and 4-methyl-1,2-pentanediol; alkyl alcohols having 1 to 4 carbon atoms such as ethanol, methanol, butanol, propanol and isopropanol;glycol ethers such as monomethyl ethylene glycol ether, monoethyl ethylene glycol ether, monobutyl ethylene glycol ether, monomethyl ethylene glycol ether acetate, monomethyl diethylene glycol ether, monoethyl diethylene glycol ether, mono-n-propyl diethylene glycol ether, mono-isopropyl ethylene glycol ether, mono-isopropyl diethylene glycol ether; mono-n-butyl ether of ethylene glycol, mono-t-butyl ether of ethylene glycol, mono-t-butyl ether of diethylene glycol, 1-methyl-l-methoxybutanol, monomethyl ether of propylene glycol, monoethyl ether of propylene glycol, mono-t-butyl ether of propylene glycol, mono-n-propyl ether of propylene glycol, mono-isopropyl ether of propylene glycol, monomethyl ether of dipropylene glycol, monoethyl ether of dipropylene glycol, mono-n-propyl ether of dipropylene glycol and mono-isopropyl ether of dipropylene glycol; 2-pyrrolidone, N-methyl-2-pyrrolidone, 1,3-dimethyl-2-imidazolidinone, formamide, acetamide, dimethyl sulfoxide, sorbitol, sorbitan, acetin, diacetinate, triacetin, sulfolane, or mixtures thereof.

[0055] According to the various embodiments, the quantity of at least one water-soluble solvent, if any, is approximately 0.1% to approximately 25%, or approximately 0.1% to approximately 2%, or approximately 0.1% to approximately 1%, or approximately 0.1% to approximately 0.8%, or approximately 0.1% to approximately 0.5%, or approximately 1% to approximately 20%, or approximately 1% to approximately 10%, or approximately 2% to approximately 8%, or any appropriate combination, sub-combination, range, or sub-range of these values ​​by weight, relative to the total weight of the anti-aging catalyst composition. However, those skilled in the art will appreciate that other ranges fall within the scope of the invention.In some embodiments, the anti-aging catalyst composition includes more than one water-soluble solvent, each water-soluble solvent being present in an amount such as indicated above, in which each different water-soluble solvent may be present in one of the ranges selected from the ranges indicated above.

[0056] Thus, each water-soluble solvent or combination of water-soluble solvents, as appropriate, may be present by weight, relative to the total weight of the anti-aging catalyst composition, at a rate of approximately 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 to approximately 25 percent by weight, relative to the weight of the anti-aging catalyst composition, including intermediate increments and ranges. OTHER INGREDIENTS

[0057] In some embodiments, one or more optional active ingredients or other ingredients (here, “additives”) may be present in the composition of the anti-aging catalyst.

[0058] In certain embodiments, the anti-aging catalyst composition may include additional ingredients, including, but not limited to, pH adjusters, chelating agents, skin actives, humectants, skin penetrating agents, antioxidants, plant extracts, vegetable oils and butters, perfumes, fillers, powders, clays, pearlescent agents, odor absorbers, coloring materials and dyes, essential oils, Vitamins, antimicrobials and preservatives, oils (of natural and synthetic origin, including but not limited to silicone oils, hydrocarbon-based oils and waxes), as well as surfactants, emulsifiers, and combinations thereof. Non-exhaustive examples of some and other optional additional ingredients are provided below.

[0059] In certain embodiments, the anti-aging catalyst composition excludes any or a combination of pH correctors, chelating agents, skin actives, humectants, skin penetrating agents, antioxidants, plant extracts, vegetable oils and butters, perfumes, fillers, powders, clays, pearlescent agents, odor absorbers, coloring materials and dyes, essential oils, vitamins, antimicrobials and preservatives, oils (of natural and synthetic origin, including but not limited to silicone oils, hydrocarbon-based oils and waxes), as well as surfactants, emulsifiers, or any combination thereof.

[0060] In certain embodiments, the anti-aging catalyst composition may include ingredients selected from: chelating agents, such as trisodium ethylenediamine disuccinate, ethylenediaminetetraacetic acid (EDTA), tetrasodium glutamate diacetate, tetrasodium etidronate, tetrasodium pyrophosphate, pentasodium ethylenediamine tetramethylenephosphonate, sodium staminate and combinations thereof; humectants, such as acetamide MEA; dihydroxylated and trihydroxylated alcohols, such as glycerin, ethoxydiglycol, propylene glycol, propanediol, butylene glycol, dipropylene glycol, pentylene glycol, hexylene glycol, or combinations thereof; antimicrobials;antioxidants, including, but not limited to, phenolic compounds such as chalcones, flavones, flavanones, flavanols, flavonols, dihydroflavonols, isoflavonoids, neoflavonoids, catechins, anthocyanidins, tannins, lignans, aurones, stilbenoids, curcuminoids, alkylphenols, betacyanins, capsacinoids, hydroxybenzoketones, methoxyphenols, naphthoquinones and phenolic terpenes, resveratrol, curcumin, pinoresinol, ferulic acid, hydroxytyrosol, cinnamic acid, caffeic acid, p-coumaric acid, baicalin (Scutellaria Baicalensis root extract), pine bark extract (Pinus Pinaster bark / bud extract), ellagic acid; hyaluronic acid and its derivatives; escin (also known as Aescin, a mixture of saponins with anti-inflammatory, vasoconstrictive and vasoprotective effects found in Aesculus hippocastanum; hydroxyacetophenone and 4-hydroxyacetophenone;and vitamins and vitamin derivatives, such as vitamin A, vitamin C (1-ascorbic acid, acetyl-C (3-O-ethyl ascorbic acid), magnesium ascorbyl phosphate, sodium ascorbyl phosphate, tetrahexyldecyl ascorbate, ascorbyl glucoside, or any combination thereof), vitamin E (tocopherol, alpha-tocopherol, beta-tocopherol, ; delta-tocopherol, gamma-tocopherol, alpha-tocotrienol, beta-tocotrienol, delta-tocotrienol, gamma-tocotrienol and their derivatives), vitamin D, calcium pantothenate; piroctone olamine; phenylethyl resorcinol; escin; retinol; citric acid; hydroxypropyl tetrahydropyrantriol; sequestrants; niacinamide, pyruvic acid; UV filters and UV amplifiers; dispersants; ceramides; opacifiers; or any combination thereof.

[0061] In certain embodiments, one or more additives may be selected from fillers and / or clays of mineral or organic, natural or synthetic origin to provide oil absorption or optical effects. Oil-absorbing fillers may impart a matte finish and a non-greasy feel to the skin. Optical effect fillers may give the skin an artistic blurring / veiling / blurring effect, make the skin appear more even, reduce the appearance of skin imperfections or discolorations, or minimize the visibility of pores. A filler may include boron nitride, a crosslinked methyl methacrylate polymer, mica, zea may (maize) starch, magnesium oxide, nylon-12, nylon-66, cellulose, polyethylene, talc, talc (and) methicone, talc (and) dimethicone, perlite, sodium silicate, pumice, PTFE, ammonium polyacryloyldimethyl taurate,polymethyl methacrylate, oryza sativa (rice) starch, aluminum starch octenylsuccinate, modified potato starch, alumina, calcium sodium borosilicate, magnesium carbonate, hydrated silica, crosslinked dimethicone / vinyl dimethicone polymer, sodium carboxymethyl starch, bismuth oxychloride, silica silylate, boron nitride, iron oxide, calcium carbonate, calcium sulfate (and) iron oxides, aluminum, potassium, and sodium silicate, silica, silica (and) methicone, silica (and) dimethicone, polysilicone-22, polysilicone-8, polysilicone-11, crosslinked methyl methacrylate polymer, polymethylsilsesquioxane, a crosslinked methylsilanol / silicate polymer, a crosslinked vinyl dimethicone / methicone silsesquioxane polymer, a crosslinked diphenyl dimethicone / vinyl diphenyl dimethicone silsesquioxane polymer,a styrene / acrylates copolymer, mica (and) lauroyl lysine, synthetic fluorphlogopite (and) titanium dioxide (and) magnesium silicate (and) tin oxide, synthetic fluorphlogopite (and) titanium dioxide (and) tin oxide, titanium dioxide, or any combination thereof. Clays may include smectite, sodium smectite, calcium smectite, illite, chlorite, vermiculite, atapulgite, phylosilicates, kaolinites, bentonite, hectorite, kaolin, silicates, aluminum and magnesium silicate, montmorillonite (volcanic minerals), or any combination thereof.

[0062] In some embodiments, the additives may include an antimicrobial agent or a combination of antimicrobial agents and their salts, for example, including, but not limited to, the group consisting of chlorphenesin, caprylyl glycol, phenoxyethanol, caprylhydroxamic acid, benzoic acid, salicylic acid, benzyl alcohol, phenethyl alcohol, benzalkonium chloride, 4-hydroxyacetophenone, piroctone olamine, hexylglycerin, ethylhexylglycerin, octylglycerin, benzylglycerin, 3-heptoyl-2,2-propanediol, and 1,2-hexanediol, and pentylene glycol, and a combination thereof.

[0063] In certain embodiments, one or more additives may be selected from penetrants or penetration enhancers selected from ethoxydiglycol, dimethyl isosorbide, sodium dilauramidoglutamide lysine, fatty acid polyglyceryl ester, laurocapram, dipropylene glycol, propylene glycol, or one of their combinations.

[0064] In some embodiments, the additives may include one or a combination of cosmetic oils. In some embodiments, the oil is generally immiscible with water. The oil may be selected from hydrocarbons, silicones, fatty alcohols, glycols, and vegetable oils. The oil may include a polar or nonpolar oil or a combination thereof. In some embodiments, the oil may be selected from hydrocarbon-based oils derived from plants or of vegetable origin, mineral oil, ester oils, fatty alcohols containing 12 to 26 carbon atoms, fatty acids containing 12 to 26 carbon atoms, and vinylpyrrolidone copolymers, or a combination thereof.

[0065] In some embodiments, the additives may include one or a combination of nonionic, cationic, anionic or zwitterionic surfactant, or a combination thereof.

[0066] In some embodiments, the additives may include a thickener or a combination of thickeners, such as natural gums and synthetic polymers, for example, the thickener may be selected from the group consisting of starches (maize, rice, tapioca, potato), gums (xanthan gum, carrageenan, gellan gum, sclerotium, tarabiotech fermentation), hydroxypropyl guar gum, Ceratonia siliqua (carob) gum, a C10-30 acrylate / alkyl acrylate crosslinked polymer, a carbomer, ammonium polyacryloyldimethyltaurate, ammonium acryloyldimethyltaurate / steareth-25 methacrylate crosslinked polymer, and polyacrylate-6 crosslinked polymer, or a combination thereof.

[0067] In some embodiments, the additives may include one or a combination of alcohols, for example, monoalcohols such as C1-C8 monohydric alcohols such as ethanol, propanol, butanol, isopropanol, isobutanol and benzyl alcohol, and phenylethyl alcohol, or one of their combinations.

[0068] Although the optional additives are given by way of example, it will be appreciated if other optional components compatible with known cosmetic applications in the art are suitable and can be used. It will be appreciated by a qualified person that all optional additives are present only to the extent and in quantities that do not materially and negatively affect the fundamental and innovative feature(s) of the claimed disclosure. Thus, in certain embodiments that include optional additives, these optional additives will not materially and negatively affect the solubility of the skin actives in the anti-aging catalyst composition. And, in certain embodiments that include optional additives, these optional additives will not materially and negatively affect the stability or activity of the anti-aging catalyst composition.

[0069] To avoid any ambiguity, in certain embodiments, the anti-aging catalyst composition excludes any one or a combination of the previously listed active components and additives.

[0070] In certain embodiments, the anti-aging catalyst composition is free or substantially free of at least one active ingredient selected from the group consisting of ascorbic acid and other forms of vitamin C, ferulic acid, gallic acid, zinc PCA, azelaic acid, chlorogenic acid and vitamin E, or one of their combinations.

[0071] In certain embodiments, the anti-aging catalyst composition is free from or minimizes the use of non-renewable ingredients (for example, mineral oil and petroleum-based ingredients) and ingredients that have a negative environmental impact (for example, EDTA, which mobilizes heavy metals). Thus, in certain embodiments, the anti-aging catalyst composition is free from or essentially free from ingredients selected from the group consisting of parabens, phthalates, cyclomethicones, a silicone, a mineral oil, petroleum-based ingredients, synthetic dyes, sulfates, a polyquaternium, microplastics, EDTA, silicone oils, mineral UV blockers, organic UV blockers, or any combination thereof.

[0072] According to the various embodiments, the quantity of additives, for example, active ingredients and other components, when present in the anti-aging catalyst composition, can range from about 0.001% to about 50%, or from about 0.5% to about 30%, or from about 1.5% to about 20%, or from about 5% to about 15%, or any appropriate combination, sub-combination, range or sub-range of these values ​​by weight, relative to the total weight of the anti-aging catalyst composition.

[0073] In certain embodiments, one or more additives, alone or in combination, may be present in the composition of the anti-aging catalyst at a rate from about 0.05% to about 50% by weight, from about 0.05% to about 25% by weight, from about 0.1% to about 10%, from about 0.25% to about 5%, and from about 0.5% to about 3.5%, from about 0.05% to about 2.5%, from about 0.1% to about 2%, from about 0.25% to about 1.5%, or from about 0.5% to about 1.25%, or any appropriate combination, subcombination, range or subrange of these values ​​by weight, relative to the weight of the anti-aging catalyst composition.

[0074] Thus, an additive or a combination of additives, as appropriate, may be present in the anti-aging catalyst composition, by weight, relative to the weight of the anti-aging catalyst composition, each or the combination being present in a quantity of approximately 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.10, 0.20, 0.30, 0.40, 0.50, 0.60, 0.70, 0.0 ... 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 at approximately 50 percent by weight, including increments and intermediate ranges. Example 1#: Raw Materials

[0075] The percentages of each ingredient as given by way of example in the example embodiment of an anti-aging catalyst composition are indicated as the quantity of active ingredient, the raw materials being able to be present in an amount equal to the amount of active ingredient, or if the raw material has an active ingredient concentration of less than 100%, the anti-aging catalyst composition includes the raw material which includes the active ingredient and a suitable solvent, the concentration of active ingredient in the raw material being provided here below in Table 1. If a raw material is not listed in the table, it shall be assumed that it has an active ingredient concentration essentially of 100%.

[0076] [Table 1]

[0077] TABLE 1: Selecting raw materials (including raw materials with active ingredient concentrations below 100%) Ingredient Source Percentage of active ingredients (if less than 100%) GLYCOLIC ACID GUANGAN CHENGXIN CHE MICAL, CHEMOURS 70 LACTIC ACID CORBION PRODUTOS RENO VAVEIS 90 MANDELIC ACID KUMAR ORGANICS PRODUC TS LIMITED PHYTIC ACID TSUNO RICE FINE CHEMICA LS 50 SALICYLIC ACID JQC (HUAYIN) PHARMACEU TICAL, ALTA LABORATORIE S, NOVACYL TAURINE JIANGSU YUANYANG PHAR M SOLD QUIMDIS, QIANJIAN G YONGAN PHARMA

[0078] Example 2: Composition of the anti-aging catalyst of the invention

[0079] [Table 2]

[0080] TABLE 2: Composition of the anti-aging catalyst of the invention Ingredient Anti-aging Catalyst INV 1 CHLORPHENESINE 0.20 TAURINE 1.0 CAPRYLYL GLYCOL 0.20 ETHOXIDIGLYCOL 2.40 SODIUM HYDROXIDE 1.75 TETRASODIUM GLUTAMATE DIACETATE 0.048 GLYCERIN 3.00 SALICYLIC ACID 0.20 WATER 83.70 GLYCOLIC ACID 2.5 LACTIC ACID 2.0 PHYTIC ACID 2.00 MANDELIC ACID 1.00

[0081] Note: the quantities represent the final concentration of the active ingredient, although some active ingredients supplied in the MP may have an active ingredient concentration of less than 100%

[0082] The foregoing represents an example of an embodiment of the invention; other embodiments are possible in accordance with the description presented here above.

[0083] Example 3: Taurine-induced NAD+ stimulation studies

[0084] At-home micro-scrubs are a convenient and effective way for individuals to perform gentle chemical exfoliations in the comfort of their own homes. These skincare treatments involve the application of mild exfoliating solutions to help improve skin texture, clarity, and radiance without the need for professional intervention.2 At-home micro-scrubs are especially popular among those seeking to address minor skin concerns and achieve a fresher, smoother complexion. Generally, AHAs, such as glycolic acid and lactic acid, work to exfoliate the outer layer of skin, while BHAs, such as salicylic acid, can penetrate deeper into pores, making them suitable for treating acne and clogged pores.The chemical solution gently dissolves dead skin cells, promoting cell renewal and stimulating the growth of new, healthier skin.

[0085] CE Ferulic is a cutting-edge antioxidant serum. This potent formula combines 15% pure vitamin C (L-ascorbic acid), 1% vitamin E (alpha-tocopherol), and 0.5% ferulic acid. The unique blend of these ingredients provides superior protection against environmental stressors, such as UV rays and pollution, which can lead to premature aging and skin damage. The high concentration of vitamin C in CE Ferulic has been scientifically proven to neutralize free radicals, stimulate collagen synthesis, and brighten skin tone.3,4 Regular use of CE Ferulic has been clinically shown to improve skin texture, reduce the appearance of fine lines and wrinkles, and promote a more even and radiant complexion.

[0086] The in vitro tests described herein examine a micro-exfoliation, CEFerulic, and the combination of an anti-aging catalyst composition with the CEFerulic formula using reconstructed skin. The anti-aging catalyst composition can maximize the results, while amplifying the benefits, of at-home skincare. The note details the study on the micro-exfoliation with the anti-aging catalyst composition, CEFerulic products, and also the effects of combining the anti-aging catalyst composition with CEFerulic. In addition, the anti-aging catalyst composition formula also included taurine as an active ingredient, which is intended to complement the function of the serum in the anti-aging catalyst composition by amplifying the NAD+ level in cells.

[0087] NAD+ plays an important role in cellular energy metabolism, as it forms reduced NADH, which provides reduction equivalents of the mitochondrial electron transport chain (ETC) to fuel oxidative phosphorylation. However, the role of NAD+ has expanded beyond its role as a coenzyme, Because NAD+ and its metabolites also act as degradation substrates for a wide range of enzymes, such as sirtuins,1 the role of NAD+ as a coenzyme in most metabolic pathways suggests that limitations in NAD+ could affect metabolic efficiency. Therefore, decreased NAD+ levels could lead to the development of many age-related diseases.1

[0088] Taurine is one of the most abundant free amino acids in mammalian tissues, and its concentration in intracellular spaces reaches millimolar levels in certain cell types. In a previous study, oral taurine supplementation was able to suppress UVB-induced wrinkle formation, which may be associated with the regulation of moisture content in the epidermis. The beneficial effects of taurine on skin aging may be attributed to its osmoregulatory role.2 Furthermore, dietary taurine supplementation improves MDA, GSSG / GSH, and NAD+ / NADH levels in the precataractic diabetic lens.3 References

[0089] 1. Canto C, Menzies KJ, Auwerx J. NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab. Jul 7, 2015; 22(1):31-53.

[0090] 2. Yoshimura T, Manabe C, Inokuchi Y, Mutou C, Nagahama T, Murakami S. Protective effect of taurine on UVB-induced skin aging in hairless mice. Biomed Pharmacother. Sep 2021 ; 141:111898.

[0091] 3. Obrosova IG, Stevens MJ. Effect of dietary taurine supplémentation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Invest Ophthalmol Vis Sci. Mar 1999 ; 40(3):680-8.

[0092] ÉTUDES DE STIMULATION DE NAD+ INDUITE PAR LA TAURINE

[0093] Cell studies were conducted in which the effects of taurine and niacinamide on NAD+ production were evaluated when keratinocytes were cultured with these raw materials. In all test conditions supplemented with active substances, the NAD+ levels in the cells increased compared to the untreated control. It was found that 0.2% niacinamide appeared to induce a higher level of NAD+ compared to 0.05% niacinamide. It was found that 0.05% taurine induced a comparable level of NAD+ compared to 0.2% niacinamide.

[0094] Taurine has been identified as an interesting active ingredient for skincare due to its potential benefits in boosting cellular energy. This report explores the effect of taurine supplementation on keratinocytes to understand its effect on increasing NAD+ levels in cells. This report demonstrates that Taurine has a stimulating effect on increasing NAD+ levels and is the subject of future trials to fully understand its effect on cellular metabolism. In our in vitro study, we observed that CEF confers significant benefits to the cell cycle and cell division. When combined with an anti-aging catalyst composition, the treatment not only enhances the benefits of skin renewal and resurfacing but also maintains the positive effects on the cell cycle and cell division. This is evident in the more pronounced impact on pathways related to skin cornification and epidermal development compared to the single-type treatment.

[0095] Example 4: Additional study results (see appendix)

[0096] The articles "a" and "an" as used herein mean one or more when applied to any particular feature in embodiments of the present invention described in the specification and claims. The use of "a" and "an" does not limit the meaning to a single feature unless such a limitation is specifically stated. The articles "the," "a," or "them" preceding singular or plural nouns or noun phrases denote a specified particular feature or features and may have a singular or plural connotation depending on the context in which it is used. The adjectives "any" and "all" mean one, some, or all indiscriminately, regardless of quantity.

[0097] “At least one”, as used herein, means one or more and thus includes individual components as well as mixtures / combinations.

[0098] The transitional expressions "comprising," "consisting essentially of," and "consisting of," when used in the appended claims, in their original and amended forms, define the scope of the claims with respect to any additional elements or steps not mentioned, which are excluded from the scope of the claim(s). The term "comprising" is intended to be inclusive or broad and does not exclude any additional, unmentioned element, process, step, or material. The expression "consisting of" excludes any element, step, or material other than those specified in the claims and, in the latter case, impurities ordinarily associated with the specified material(s).The expression "essentially consisting of" limits the scope of a claim to the specified elements, steps, or material(s) and to those that do not materially affect the fundamental and novel feature(s) of the claimed invention. All the processes and materials described herein that incorporate the present invention can, in alternative embodiments, be defined more specifically by any of the transitional expressions "comprising," "essentially consisting of," and "consisting of."

[0099] Apart from the examples of operation, or unless otherwise indicated, all numbers expressing quantities of ingredients and / or reaction conditions preceded by the word "about" should be understood as being modified in all cases to mean 10% of the number indicated (for example, "about 10%" means 9% to 11% and "about 2%" means 1.8% to 2.2%).

[0100] All percentages and ratios are, unless otherwise stated, calculated by weight. All percentages are, unless otherwise stated, calculated relative to the total composition. In general, unless expressly stated otherwise herein, "weight" or "quantity" as used herein with respect to the percentage quantity of an ingredient refers to the quantity of raw material comprising the ingredient, the raw material being described herein as comprising less than and up to 100% of the ingredient's activity. Therefore, the weight percentage of an active ingredient in a composition is represented as the quantity of raw material containing the active ingredient that is used and may or may not reflect the final percentage of the active ingredient, the final percentage of the active ingredient being dependent on the weight percentage of the active ingredient in the raw material.

[0101] All ranges and quantities given herein are intended to include subranges and quantities using any disclosed point as a boundary. Thus, a range of "1% to 10%, such as 2% to 8%, such as 3% to 5%" is intended to encompass ranges of "1% to 8%", "1% to 5%", "2% to 10%", and so on. All figures, quantities, ranges, etc., are intended to be modified by the term "approximately", whether or not expressly stated. Similarly, a given range of "approximately 1% to 10%" is intended to have its boundaries of both 1% and 10% modified by the term "approximately". Furthermore, it is understood that where a quantity of a component is given, it is intended to mean the quantity of the active material, unless specifically stated otherwise.

[0102] Although the numerical ranges and parameters presenting the general scope of the disclosure are approximations, unless otherwise indicated, the numerical values ​​presented in the specific examples are reported as accurately as possible. However, every numerical value inherently contains some errors necessarily resulting from the standard deviation observed in their respective test measurements. The following example serves to illustrate embodiments of this disclosure but is not, however, limiting in nature.

[0103] Although the invention has been described with reference to a preferred embodiment, a person skilled in the art will understand that various changes can be made and equivalents can replace elements without departing from the scope of the invention. Furthermore, numerous modifications can be made to adapt a particular situation or subject matter to the teachings of the invention without departing from its essential scope. Therefore, the invention is not limited to a particular embodiment disclosed as being the best embodiment envisaged to implement this invention, but the invention shall include all embodiments within the scope of the attached claims.

Claims

Demands

1. Anti-aging catalyst composition comprising: a mixture of cosmetically acceptable acids including at least one beta-hydroxy acid and at least three alpha-hydroxy acids, and one or more other cosmetically acceptable acids; and a cosmetically acceptable solvent including at least water, wherein the pH of the skin care composition is in a range of pH 3.6 to pH 3.

9.

2. Anti-aging catalyst composition according to claim 1, comprising at least one amino acid comprising at least taurine.

3. Anti-aging catalyst composition according to claim 1 or 2, wherein one or more other cosmetically acceptable acids that are not an alpha- or beta-hydroxy acid include at least phytic acid.

4. Anti-aging catalyst composition according to any one of the preceding claims, wherein the cosmetically acceptable acid mixture includes at least salicylic acid, glycolic acid, lactic acid, mandelic acid and phytic acid.

5. Anti-aging catalyst composition according to claim 4, wherein the cosmetically acceptable acid mixture which includes at least salicylic acid, glycolic acid, lactic acid, mandelic acid and phytic acid is present in the composition in a total amount of 7.7%, by weight, relative to the total weight of the anti-aging catalyst composition.

6. Anti-aging catalyst composition according to any one of the preceding claims, wherein the total amount of cosmetically acceptable acid is present in a range of 1% to 70%

7. / V. Anti-aging catalyst composition according to any one of the preceding claims, wherein each of the cosmetically acceptable acids in the anti-aging catalyst composition is present in a range of 0.1% to 69%, and wherein the anti-aging catalyst composition has a pH ranging from pH 1 to pH 5.

5.

8. Anti-aging catalyst composition according to any one of the preceding claims, wherein the anti-aging catalyst composition excludes any or a combination of pH adjusters, chelating agents, skin actives, humectants, skin penetrating agents, antioxidants, plant extracts, vegetable oils and butters, perfumes, fillers, powders, clays, pearlescent agents, odor absorbers, coloring materials and dyes, essential oils, vitamins, antimicrobials and preservatives, oils (of natural and synthetic origin, including but not limited to silicone oils, hydrocarbon-based oils and waxes), as well as surfactants, emulsifiers, or any combination thereof.

9. Anti-aging catalyst composition according to any one of the preceding claims, wherein the anti-aging catalyst composition excludes any or a combination of parabens, phthalates, cyclomethicones, silicone, mineral oil, petroleum-based ingredients, synthetic dyes, sulfates, polyquatemium, microplastics, EDTA, silicone oils, mineral anti-UV agents, organic anti-UV agents, or any combination thereof.

10. Anti-aging catalyst composition according to any one of the preceding claims, wherein the anti-aging catalyst composition excludes any or a combination of ascorbic acid and other forms of vitamin C, ferulic acid, gallic acid, zinc pca, azelaic acid, chlorogenic acid, and vitamin E, or any combination thereof.